Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Total 13F shares
-
18,461,446
-
Share change
-
+3,516,458
-
Total reported value
-
$490,151,655
-
Price per share
-
$26.55
-
Number of holders
-
34
-
Value change
-
+$93,408,079
-
Number of buys
-
23
-
Number of sells
-
7
Institutional Holders of MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) as of Q3 2018
As of 30 Sep 2018,
MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,461,446 shares.
The largest 10 holders included
BB BIOTECH AG, RA CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, EVENTIDE ASSET MANAGEMENT, LLC, LORD, ABBETT & CO. LLC, NovaQuest Capital Management, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, NORGES BANK, ADAGE CAPITAL PARTNERS GP, L.L.C., and MILLENNIUM MANAGEMENT LLC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.